Provided by Tiger Trade Technology Pte. Ltd.

Biomerica

2.58
0.0000
Post-market: 2.580.00000.00%16:15 EST
Volume:15.10K
Turnover:38.60K
Market Cap:7.61M
PE:-1.20
High:2.61
Open:2.53
Low:2.50
Close:2.58
52wk High:10.16
52wk Low:2.08
Shares:2.95M
Float Shares:2.94M
Volume Ratio:0.47
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1422
EPS(LYR):-2.8430
ROE:-69.61%
ROA:-41.49%
PB:1.48
PE(LYR):-0.91

Loading ...

Egyptian Drug Authority Approves Biomerica's Full Portfolio of Rapid Screening Tests

Reuters
·
Dec 11

Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

GlobeNewswire
·
Nov 25

BRIEF-Biomerica Expands Contract Development And Manufacturing Services To Meet Growing Market Demand

Reuters
·
Nov 06

Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

GlobeNewswire
·
Nov 06

Biomerica Says Irritable Bowel Syndrome Test to be Marketed by Henry Schein in US

MT Newswires Live
·
Oct 16

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.

GlobeNewswire
·
Oct 16

Medical diagnostic firm Biomerica's Q1 revenue falls on lower retail activity

Reuters
·
Oct 15

Press Release: Biomerica Reports First Quarter Fiscal 2026 Financial Results

Dow Jones
·
Oct 15

Biomerica Q1 Sales $1.380M Down From $1.807M YoY

Benzinga
·
Oct 15

Biomerica Inc announces date for annual meeting of stockholders

Reuters
·
Oct 10

Press Release: Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

Dow Jones
·
Oct 08

Biomerica Inc. Files Amendment to 2025 Annual Report

Reuters
·
Sep 27

Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

GlobeNewswire
·
Sep 09

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use

GlobeNewswire
·
Sep 03

BRIEF-Biomerica Reports Fiscal 2025 Year End Results

Reuters
·
Aug 30

Press Release: Biomerica Reports Fiscal 2025 Year End Results

Dow Jones
·
Aug 30

Biomerica Inc. Reports 2% Decline in Net Sales for Fiscal Year Ending May 31, 2025, with Total Revenue at $5.31 Million

Reuters
·
Aug 30

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Home Use

GlobeNewswire
·
Aug 14

Biomerica Inc. Unveils Investor Presentation Highlighting Diagnostic Innovations and Personalized Therapies

Reuters
·
Jul 17

Press Release: Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

Dow Jones
·
Jun 26